<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00116493</url>
  </required_header>
  <id_info>
    <org_study_id>H.22.03.04.22.A2</org_study_id>
    <secondary_id>Thrasher Research Fund 02817-9</secondary_id>
    <nct_id>NCT00116493</nct_id>
  </id_info>
  <brief_title>Severe Anemia Treatment Trials, Pakistan</brief_title>
  <official_title>Evaluation of Anthelminthics and Multivitamins for Treatment of Severe Anemia in Pregnant Women and Children 6-24 Months of Age in Pakistan</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johns Hopkins Bloomberg School of Public Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Aga Khan University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Johns Hopkins Bloomberg School of Public Health</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to test the efficacy of two enhanced regimens (deworming and
      multivitamins) in the treatment of severe anemia in pregnant women and children 6-24 months
      of age in Karachi, Pakistan.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Anemia continues to be a public health problem of global proportions. Severe anemia
      (hemoglobin, Hb&lt; 70 g/L) is of special concern as it poses a significant health and mortality
      risk. Pregnant women and young children (6-24 months of age) are the two groups at highest
      risk. Severe anemia in pregnant women is associated with an elevated risk of maternal and
      perinatal mortality as well as case fatality. Pakistan, the country in which this study is
      ongoing, may harbor the highest prevalence of severe anemia in South Asia, with as high as
      15% being reported among pregnant women. Comparable rates (11-12%) are also seen among 6-24
      month old children. Iron deficiency is one of the major causes of anemia in young children
      and pregnant women in South Asia. In addition to iron, deficiency of vitamins such as folic
      acid, vitamin A, vitamin C, riboflavin and vitamin E can also inhibit erythropoiesis. Apart
      from these nutritional causes, two other infectious causes of severe anemia are malaria and
      geohelminths. The current international recommendation for treatment of anemia includes iron
      and folic acid but not other vitamins.

      Comparisons: Severely anemic pregnant women and children 6-24 months are randomized to
      receive enhanced treatment of deworming and multivitamins over and above the standard of care
      of iron-folic acid using a 2x2 factorial design.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2004</start_date>
  <completion_date type="Actual">May 2007</completion_date>
  <primary_completion_date type="Actual">May 2007</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Severe Anemia</measure>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">1009</enrollment>
  <condition>Anemia</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Standard of care (Iron-folic acid + Deworming)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Iron-folic acid and mebendazole</intervention_name>
    <description>100 mg iron for pregnant women, 25 mg iron for children
1 mg of folic acid for pregnant women, 100 ug folic acid for children 500 mg of mebendazole for both pregnant women and children</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Mebendazole</intervention_name>
    <description>100 mg twice a day for 3 days; Iron-folic acid also given</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Multivitamins</intervention_name>
    <description>Iron-folic acid also given; Includes vitamins A, C, B12, E, and B2</description>
    <arm_group_label>3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Mebendazole + Multivitamin</intervention_name>
    <description>Multivitamins + Mebendazole at 100 mg twice a day for 3 days; Iron-folic acid also given</description>
    <arm_group_label>4</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pregnant women with severe anemia (Hb&lt;70g/L)

          -  Children 6-24 months with severe anemia (Hb&lt;70 g/L)

        Exclusion Criteria:

          -  Gestational age &gt;=36 weeks

          -  Edema

          -  Breathlessness
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Parul Christian, DrPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johns Hopkins Bloomberg School of Public Health</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Aga Khan University</name>
      <address>
        <city>Karachi</city>
        <state>Sindh</state>
        <country>Pakistan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Pakistan</country>
  </location_countries>
  <results_reference>
    <citation>Bhutta Z, Klemm R, Shahid F, Rizvi A, Rah JH, Christian P. Treatment response to iron and folic acid alone is the same as with multivitamins and/or anthelminthics in severely anemic 6- to 24-month-old children. J Nutr. 2009 Aug;139(8):1568-74. doi: 10.3945/jn.108.103507. Epub 2009 Jun 17.</citation>
    <PMID>19535425</PMID>
  </results_reference>
  <results_reference>
    <citation>Christian P, Shahid F, Rizvi A, Klemm RD, Bhutta ZA. Treatment response to standard of care for severe anemia in pregnant women and effect of multivitamins and enhanced anthelminthics. Am J Clin Nutr. 2009 Mar;89(3):853-61. doi: 10.3945/ajcn.2008.26826. Epub 2009 Jan 28.</citation>
    <PMID>19176737</PMID>
  </results_reference>
  <verification_date>April 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 29, 2005</study_first_submitted>
  <study_first_submitted_qc>June 29, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 30, 2005</study_first_posted>
  <last_update_submitted>April 6, 2012</last_update_submitted>
  <last_update_submitted_qc>April 6, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 9, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Johns Hopkins Bloomberg School of Public Health</investigator_affiliation>
    <investigator_full_name>Parul Christian</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>severe anemia</keyword>
  <keyword>anthelminthic</keyword>
  <keyword>multivitamins</keyword>
  <keyword>pregnancy</keyword>
  <keyword>children</keyword>
  <keyword>Pakistan</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Iron</mesh_term>
    <mesh_term>Folic Acid</mesh_term>
    <mesh_term>Vitamin B Complex</mesh_term>
    <mesh_term>Mebendazole</mesh_term>
    <mesh_term>Piperazine</mesh_term>
    <mesh_term>Piperazine citrate</mesh_term>
    <mesh_term>Anthelmintics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

